_2020-in-review-olaparib-amp-rucaparib-fda-approval-124-ask-a-prostate-expert-mark-scholz-md-preview-1.jpg "2020 In Review: Olaparib & Rucaparib, FDA Approval | Ask a Prostate Expert, Mark Scholz, MD from olaparib prostate cancer Video Screenshot Preview 1")
Gallery_2020-in-review-olaparib-amp-rucaparib-fda-approval-124-ask-a-prostate-expert-mark-scholz-md-preview-3.jpg "2020 In Review: Olaparib & Rucaparib, FDA Approval | Ask a Prostate Expert, Mark Scholz, MD from olaparib prostate cancer Video Screenshot Preview 3")
Gallery_2020-in-review-olaparib-amp-rucaparib-fda-approval-124-ask-a-prostate-expert-mark-scholz-md-preview-hqdefault.jpg "2020 In Review: Olaparib & Rucaparib, FDA Approval | Ask a Prostate Expert, Mark Scholz, MD from olaparib prostate cancer Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 3 minutes 30 seconds
👁 View: 921 times
Play Audio:👁 View: 921 times
Description:
Prostate Cancer Research Institute
Prostate Cancer Research Institute
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_dr-morgan-on-olaparib-for-metastatic-castration-resistant-prostate-cancer.webp "OncLiveTV")
⏲ 1 minute 38 seconds 👁 472
_the-benefits-of-177lu-psma-617-plus-olaparib-for-prostate-cancer.webp "VJOncology")
_the-propel-clinical-trial-exploring-olaparib-plus-abiraterone-in-mcrpc.webp "VJOncology")
_parp-inhibitors-for-metastatic-hormone-sensitive-prostate-cancer.webp "VJOncology")
_rucaparib-and-olaparib-two-new-treatments-approved-for-advanced-prostate-cancer-124-pcri.webp "Prostate Cancer Research Institute")
⏲ 5 minutes 15 seconds 👁 1.8K
_olaparib-plus-abiraterone-for-mcrpc-are-biomarkers-necessary.webp "VJOncology")
_olaparib-plus-abiraterone-could-be-a-new-first-line-treatment-option-for-mcrpc-124-fred-saad.webp "Medicine Matters oncology")
⏲ 3 minutes 41 seconds 👁 193
_niraparib-and-abiraterone-acetate-for-metastatic-castration-resistant-prostate-cancer.webp "ASCOcancer")
⏲ 2 minutes 59 seconds 👁 1.4K
_dr-morgan-on-olaparib-for-metastatic-castration-resistant-prostate-cancer.jpg)
_the-benefits-of-177lu-psma-617-plus-olaparib-for-prostate-cancer.jpg)
_the-propel-clinical-trial-exploring-olaparib-plus-abiraterone-in-mcrpc.jpg)
_parp-inhibitors-for-metastatic-hormone-sensitive-prostate-cancer.jpg)
_rucaparib-and-olaparib-two-new-treatments-approved-for-advanced-prostate-cancer-124-pcri.jpg)
_olaparib-plus-abiraterone-for-mcrpc-are-biomarkers-necessary.jpg)
_olaparib-plus-abiraterone-could-be-a-new-first-line-treatment-option-for-mcrpc-124-fred-saad.jpg)
_niraparib-and-abiraterone-acetate-for-metastatic-castration-resistant-prostate-cancer.jpg)
![[+]](/images/menu.gif){kind=small}